Sacroiliac Joint Fusion Market Size Worth $2.49 Billion by 2030: Grand View Research, Inc.

SAN FRANCISCO, April 12, 2022 /PRNewswire/ -- The global sacroiliac joint fusion market size is anticipated to reach USD 2.49 billion by 2030, registering a CAGR of 19.0% over the forecast period, according to a new report by Grand View Research, Inc. The key factors driving the market growth include a rising preference for minimally invasive surgeries, the growing aging population, and various initiatives by market players. The COVID-19 pandemic resulted in logistical bottlenecks, decreased sales & marketing activities, low demand, and other challenges for market participants. The major impact during the pandemic, however, was the cancelled/postponed elective surgeries. As many countries went under lockdown and implemented movement restrictions, the number of elective surgeries plummeted.

Key Insights & Findings from the report:

• The degenerative sacroiliitis indication segment dominated the market in 2021 due to the high geriatric population and prevalence of chronic conditions.
• The rapidly growing adoption of minimally invasive surgeries contributed to the dominant share of the surgery treatment type segment in 2021.
• The hospital end-user segment held the largest share of the global revenue in 2021 as hospitals are the primary Point-of-Care (POC) for treatment.
• Furthermore, hospitals offer superior care to their patients, and treatment cost is generally reimbursed, which drives the segment growth.
• The Ambulatory Surgical Centers (ASCs) segment is anticipated to register the fastest CAGR over the forecast years.
• This is owing to significantly lower procedure costs lower infection risk and high patient satisfaction than hospitals.

Read 150-page market research report, "Sacroiliac Joint Fusion Market Size, Share & Trends Analysis Report By Treatment Type (Surgery, RF Ablation), By Indication (Trauma, Sacral Disruption), By End-user (Hospital, ASC), By Region, And Segment Forecasts, 2022 - 2030", published by Grand View Research.

Sacroiliac Joint Fusion Market Growth & Trends

Several healthcare institutions and regulatory bodies recommended the postponement of elective surgical procedures. The Harvard Business Review estimated an approximately 4.8% GDP decline in the U.S. economy, in the first quarter of 2020, which could be attributed to the postponed healthcare services, particularly delayed elective procedures. The demand is anticipated to increase with the resumption of elective surgeries. The rising adoption of minimally invasive surgeries is a major factor contributing to the market growth. For instance, in September 2021, Core Link Surgical reported that its patented Entasis SI Joint Fusion System surpassed 5,000 implants.

The growing aging population in developed countries, such as the U.S., and the increasing prevalence of chronic diseases are leading to a rise in the number of surgeries performed every year. As per the U.S. Census Bureau in 2019, out of the 328 million U.S. population, about 75 million were aged 60 years and older. This implies that a significant number of the population is vulnerable to degenerative sacroiliitis and sacral disruption leading to an increased number of SI joint fusion surgeries. Many companies specializing in spine, orthopedic, or musculoskeletal solutions hold a significant share of the market. These players are involved in increasing their market share through R&D, product launches, geographical expansions, and partnerships.

For example, in March 2021, Aurora Spine, operating in spinal implant & pain management markets, launched the SiLO Posterior SI Joint Fusion System. In February 2020, Genesys Spine launched its Sacroiliac Joint Fusion system consisting of partially threaded and fully threaded implants. In January 2018, Surgalign Spine Technologies, Inc., formerly known as RTI Surgical, entered the market by acquiring Zyga Technology, Inc. In July 2020, the company sold its OEM Businesses to become a pure-play global spine company and changed its name to Surgalign.

Sacroiliac Joint Fusion Market Segmentation

Grand View Research has segmented the global sacroiliac joint fusion market on the basis of indication, treatment type, end-user, and region:

Sacroiliac Joint Fusion Indication Outlook (Revenue, USD Million, 2017 - 2030)

• Degenerative Sacroiliitis
• Sacral Disruption
• Trauma

Sacroiliac Joint Fusion Treatment Type Outlook (Revenue, USD Million, 2017 - 2030)

• Surgery
• By Surgery Type
• MIS
• Open
• By Approach
• Dorsal
• Anterior
• By Product
• Implants
• Accessories
• Injections
• Diagnosis
• Treatment
• RF Ablation

Sacroiliac Joint Fusion End-user Outlook (Revenue, USD Million, 2017 - 2030)

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Others (Specialty Centers, Research & Academic Institutes)

Sacroiliac Joint Fusion Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Latin America
• Brazil
• Mexico
• Argentina
• MEA
• South Africa
• Saudi Arabia

List of Key Players of Sacroiliac Joint Fusion Market

• SI-BONE, Inc.
• PainTEQ
• CornerLoc
• SIGNUS Medizintechnik GmbH
• Globus Medical
• Orthofix Medical Inc.
• Life Spine, Inc.
• Camber Spine Technologies, LLC
• CoreLink Surgical
• Xtant Medical
• Surgalign Spine Technologies, Inc.
• Medtronic

Check out more related studies published by Grand View Research:

• Small Bone And Joint Devices Market - The global small bone and joint devices market size is anticipated to reach USD 9.6 billion by 2027 registering a CAGR of 8.3%, as per the new report by Grand View Research, Inc. Rising incidence of sports injuries inclusive of disc injury, fracture, rotator cuff injury, and others is a primary factor driving the market.
• Joint Replacement Market - The global joint replacement market size is expected to reach USD 25.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 3.4% from 2021 to 2028. The growing incidence of orthopedic diseases and the increasing number of the target population are boosting the market growth.
• Joint Reconstruction Devices Market - The global joint reconstruction devices market size is expected to reach USD 30.4 billion by 2025, according to a new report by Grand View Research, Inc. High adoption of minimally invasive surgeries across the globe has given rise to technological advancement in surgical devices and procedures. In addition, growing prevalence of joint-related conditions and changing therapeutic approaches are expected to boost the market growth.

Browse through Grand View Research's Medical Devices Industry Research Reports.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:
Sherry James
Corporate Sales Specialist, USA 
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com 
Web: https://www.grandviewresearch.com 
Grand View Compass | Grand View Pipeline 
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg